By NewsDesk @bactiman63
Hong Kong health officials report investigating a suspected ciguatoxin poisoning cases affecting two people.
The case involves two females, aged 34 and 66 respectively, who developed symptoms of ciguatoxin poisoning including abdominal pain and diarrhea about six to seven hours after consuming a marine fish for dinner at home on April 5. The latter patient also developed perioral numbness and attended the Accident and Emergency Department of Kwong Wah Hospital the next day. She was admitted for further management. Both patients are in a stable condition.
Initial inquiries revealed that the fish consumed was bought from a fish stall in Yeung Uk Road Market, Tsuen Wan, on April 4.
Ciguatera fish poisoning is not uncommon in tropical areas. It is mainly associated with the consumption of big coral reef fish which have accumulated the toxin in the body, particularly in internal organs, through eating small fish that consumed toxic algae in coral reef seas.
A larger fish is therefore more likely to carry higher amounts of the toxin. However, it is not easy to tell from the appearance of the fish whether it contains the toxin.
People affected may have symptoms of numbness of the mouth and limbs, vomiting, diarrhea, alternating sensations of coldness and hotness, and pain in the joints and muscles.
“Most people affected by ciguatoxin will recover without long-term health effects, but if excessive toxins are consumed, the circulatory and nervous systems can be affected. The toxin cannot be destroyed by cooking,” the spokesman said.
- Vancouver Canucks hockey team battle COVID-19
- Los Angeles: First reported cases of the South African and Brazilian variant
- COVID-19 pandemic situation in Iraq continues to be quite concerning
- COVID-19 vaccine in Sweden: Nine out of ten say they will most certainly or probably will say yes
- Guinea Ebola outbreak grows to 23 overall cases
- AstraZeneca’s Vaxzevria: European officials find blood clots should be listed as very rare side effect
- Lyme disease: New test is first to reliably distinguish between early- and late-stage patients